Products

L-Histidine Methyl Ester Dihydrochloride

    • Product Name: L-Histidine Methyl Ester Dihydrochloride
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 131940
    Product Name L-Histidine Methyl Ester Dihydrochloride
    Cas Number 7389-87-9
    Mdl Number MFCD00050668
    Ec Number 230-624-3
    Molecular Formula C7H13Cl2N3O2
    Molecular Weight 242.10 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 194-196 °C (dec.)
    Optical Rotation [α]20/D = +14.0° (c=5, H2O)
    Solubility Soluble in water, methanol, and DMSO
    Storage Conditions Store at 2-8 °C, under inert atmosphere, protected from moisture
    Purity ≥98%
    Smiles Cl.Cl.COC(=O)[C@@H](N)Cc1c[nH]cn1
    Inchi InChI=1S/C7H11N3O2.2ClH/c1-12-7(11)6(8)2-5-3-9-4-10-5;;/h3-4,6H,2,8H2,1H3,(H,9,10);2*1H/t6-;;/m0../s1

    As an accredited L-Histidine Methyl Ester Dihydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing L-Histidine Methyl Ester Dihydrochloride is supplied in a sealed amber glass bottle containing 25 g, with tamper-evident closure and labeled handling precautions.
    Container Loading (20′ FCL) 20′ FCL container loaded with L-Histidine Methyl Ester Dihydrochloride, securely packed in drums for safe transport.
    Shipping L-Histidine Methyl Ester Dihydrochloride should be shipped at ambient temperature, protected from moisture and light, in a sealed, airtight container. Handle with care to avoid inhalation or skin contact. Ensure compliance with local hazardous material regulations and use appropriate PPE during handling and transport.
    Storage Store L-Histidine Methyl Ester Dihydrochloride in a tightly sealed, moisture-proof container under inert gas (e.g., nitrogen or argon). Keep refrigerated at 2–8 °C, protected from light and humidity. Avoid repeated opening to prevent hydrolysis and decomposition. Use desiccant inside storage vessel. Handle in a dry environment to maintain stability.
    Shelf Life Stable for up to 2 years when stored desiccated at -20°C, protected from light and moisture.
    Application of L-Histidine Methyl Ester Dihydrochloride

    In cGMP peptide building-block synthesis, L-histidine methyl ester dihydrochloride is charged as the C-terminal-protected starting material for Fmoc-His(Trt)-OH production. The methyl ester blocks carboxylate nucleophilicity during Nα derivatization, while the dihydrochloride salt maintains imidazole in its protonated state and suppresses N-imidazole alkylation side products during Fmoc introduction. A 1.0 mol charge of the dihydrochloride is neutralized in DMF/water at 0–5 °C with 2.0–2.5 mol N,N-diisopropylethylamine before 1.05–1.15 mol Fmoc-OSu is added; pH is held at 8.0–8.5 because imidazole deprotonation becomes kinetically significant above pH 8.8, producing N-im-Fmoc regioisomer that co-crystallizes with the desired Nα-Fmoc ester and reduces optical purity to below 97.0% by chiral HPLC. The mixture is washed with 0.1 M NaHCO₃ and extracted into 2-methyltetrahydrofuran, followed by trityl protection with 1.2 mol trityl chloride in dichloromethane at 20–25 °C over 6–10 h. Saponification of the methyl ester with 1.0–1.1 mol LiOH in THF/water at 0–10 °C yields Fmoc-His(Trt)-OH after acidification and crystallization from n-heptane/ethyl acetate. Production-scale equipment includes a 2000 L glass-lined reactor with jacket temperature control accuracy of ±1 °C and a Hastelloy C-22 filter dryer; batch-to-batch enantiomeric purity drift is most commonly traced to residual water above 0.5% in the ester saponification step. Residual solvent testing follows USP <467>, and the product is released under ICH Q7 section 7.3 with identity by LC-MS, assay ≥98.0%, and specific rotation within a supplier-approved range. Terminal products are Fmoc-His(Trt)-OH building blocks entering SPPS reactors for histidine-containing therapeutic peptides such as GLP-1 receptor agonist analogs, GnRH antagonist analogs, and antimicrobial peptide candidates, ultimately isolated as lyophilized acetate or trifluoroacetate salts for parenteral formulation.

    What Limits Direct Solution-Phase Coupling of the Dihydrochloride in Gly-His-Lys Tripeptide Manufacture?

    Direct coupling of L-histidine methyl ester dihydrochloride in solution-phase tripeptide production is limited by the low solubility of the salt in aprotic solvents below 10 °C; neutralization is therefore performed in aqueous DMF before N-protected glycine activation. In the manufacture of glycyl-L-histidyl-L-lysine, an N-terminally protected glycine active ester is coupled to the neutralized histidine methyl ester at 1.0:1.05–1.20 molar equivalents in DMF/water 4:1 at 10 ± 2 °C with 1.5–2.0 mol N-methylmorpholine as base. The reaction is agitated at 150–300 rpm in a 500 L glass-lined reactor fitted with a turbidity probe because precipitation of the mono-coupled intermediate below pH 5.5 causes yield losses of 12–18% in production batches. After glycine-histidine bond formation, the C-terminal methyl ester is saponified with 1.0–1.2 mol NaOH at 5–10 °C, keeping reaction time ≤60 min to prevent imidazole ring amide formation. The intermediate is coupled to Nε-Boc-L-lysine benzyl ester through an active ester method; final deprotection removes Boc and benzyl groups by catalytic hydrogenation over 5% Pd/C at 0.3–0.5 MPa. The tripeptide is isolated as a lyophilized powder and optionally chelated with copper acetate at a Cu²⁺:tripeptide molar ratio of 1:2 to form copper tripeptide GHK-Cu. Cosmetic applications are governed by EC 1223/2009 Annex I safety assessment, with finished formulation production controlled under ISO 22716:2007 §7 for raw material handling and §8 for production, and raw material traceability assessed using ISO 16128:2016 natural origin index only if the claim requires it. Terminal formulations include anti-aging serums, hair follicle activation ampoules, and post-procedure barrier repair creams at peptide concentrations from 0.01 wt% to 0.3 wt%, while the bulk peptide raw material is supplied at assay ≥98.0% by HPLC.

    Liquid-phase peptide synthesis of histidine-containing fragments for veterinary gonadotropin-releasing hormone vaccine conjugates uses L-histidine methyl ester dihydrochloride as a C-terminal ester-protected fragment after Nα and side-chain protection. In a 1000 L baffled reactor, 1.0 mol of the methyl ester is coupled to 1.0–1.3 mol of N-Boc-D-amino acid or N-Fmoc-amino acid p-nitrophenyl ester in ethyl acetate/water biphasic medium with pH maintained at 7.8–8.2 by sodium carbonate addition. The biphasic operation is selected because the methyl ester partitions into the organic phase while the dihydrochloride-derived imidazolium species remains water-soluble until neutralization; a residence time of 4–6 h at 20–25 °C is typical before phase cut. The peptide chain is extended by repeated active ester coupling cycles, and the methyl ester is removed with 1.0 M LiOH in THF/water 3:1 at 0–5 °C only after the target sequence is assembled, because premature ester hydrolysis exposes the C-terminus to epimerization at the histidine α-carbon. Process bottlenecks include rag-layer formation during phase separation at pH >8.5, which can be reduced by adding 5 wt% sodium chloride to the aqueous phase. Terminal products are protected peptide fragments that enter conjugation to carrier proteins for animal health vaccines, including fertility control vaccines and GnRH immunocastration products. Compliance is referenced under VICH GL18 for residual solvents in veterinary medicinal product starting materials, and residual solvent limits follow Ph. Eur. general chapter 5.4 for peptide intermediates.

    When Bromination at the Imidazole C2 Position Must Precede Carboxyl Deprotection

    Preparation of 2-thio-L-histidine derivatives for ergothioneine synthesis uses L-histidine methyl ester dihydrochloride as a protected histidine platform because the methyl ester prevents oxidation of the α-carboxylate during electrophilic substitution on the imidazole ring. After neutralization of the salt with 2.0 mol NaOH in water/THF 1:1, the Nα-amino group is protected as a carbamate; subsequent bromination with 1.05 mol N-bromosuccinimide at −5 to 0 °C gives 2-bromo-histidine methyl ester. Thiolation with sodium hydrosulfide or protected thiol nucleophiles at 1.5–2.0 mol equivalents requires pH 9.0–9.5 and is monitored by HPLC because over-reduction of the ester to the corresponding alcohol occurs at pH >10.0. The methyl ester is hydrolyzed under non-aqueous HCl/dioxane at 0–5 °C to avoid dialkyl sulfide side products; batch yield loss from imidazole ring decomposition is typically highest when local pH exceeds 10.2 during sodium hydrosulfide addition, and inline pH probes with ±0.05 unit accuracy are used on 200–500 L scale. Terminal product types include ergothioneine powder and its food-grade hydrochloride for dietary supplements and antioxidant skin care formulas. Standards applied include 21 CFR Part 117 for dietary supplement cGMP, REACH EC 1907/2006 Annex VI for imported quantities above 1 metric ton/year, and supplier-specific heavy metal and residual solvent specifications because a harmonised pharmacopoeial monograph for this raw material is not available. Published industrial-scale yield data for this specific histidine methyl ester route is limited; feasibility batches are recommended before campaign commitment.

    Feed ratio and process boundary reference for protected histidine routes
    Downstream routeLimiting addition ratioObserved process boundaryControl measurement
    Fmoc-His(Trt)-OH building block1.05–1.15 mol Fmoc-OSu per 1.0 mol substratepH 8.8 imidazole deprotonation thresholdpH 8.0–8.5, 0–5 °C, chiral HPLC
    Solution-phase Gly-His-Lys tripeptide1.05–1.20 mol glycine active ester per 1.0 mol histidine methyl esterIntermediate precipitation below pH 5.5DMF/water 4:1, turbidity probe, 10 ± 2 °C
    Liquid-phase peptide fragment coupling1.0–1.3 mol p-nitrophenyl ester per 1.0 mol methyl esterRag-layer formation above pH 8.5Ethyl acetate/water, 5 wt% NaCl, pH 7.8–8.2
    2-Thio-L-histidine intermediate1.5–2.0 mol thiol nucleophile per 1.0 mol bromo intermediateRing decomposition above pH 10.2Inline pH 9.0–9.5, ±0.05 unit accuracy, HPLC

    Research-grade L-histidine methyl ester dihydrochloride is used as a substrate for esterase and protease activity screens and as a carrier ligand in immobilized metal-affinity chromatography resin masking studies, where the addition ratio is 0.1–1.0 wt% in 50 mM Tris-HCl at pH 7.4; the downstream process is dissolution and sterile filtration through a 0.22 µm polyethersulfone membrane before use; terminal products are assay-ready biochemical kits and calibration standards with compliance limited to ISO 9001:2015 supplier quality agreements and REACH Annex II SDS conformance.

    Free Quote

    Competitive L-Histidine Methyl Ester Dihydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Commercial L-Histidine methyl ester dihydrochloride, listed under the abbreviated designation H-His-OMe·2HCl and CAS 7389-87-9, is the double hydrochloride salt of L-histidine methyl ester. The linear formula C7H11N3O2·2HCl corresponds to a molecular weight of 242.10 g mol⁻¹ and a theoretical chloride content of 29.3%. The product is released as a white to off-white crystalline powder, with a vendor-specified assay of ≥98.0% by HPLC area at 210 nm on a C18 column, loss on drying of ≤0.50% by USP <731>, and residual solvent values reported against USP <467> and ICH Q3C Class 3 solvent limits. The derivative blocks the C-terminal carboxylate as a methyl ester while retaining the α-amino and imidazole functions as hydrochloride salts. This salt stoichiometry is the main difference from L-histidine and from the free ester, and it defines the product’s role as a C-terminal building block in solution-phase peptide synthesis and as an intermediate for histidine-containing peptidomimetics.

    The product is supplied in moisture-barrier packaging under inert gas and is commonly assigned catalogue model codes that encode the amino acid abbreviation, ester form, and salt stoichiometry—for example, H-His-OMe·2HCl or L-histidine methyl ester dihydrochloride. Two purity tiers are typical: research grade at ≥98.0% HPLC area and high-purity grade at ≥99.0% HPLC area with single impurity limits of ≤0.50%. The choice between grades is determined by the intended downstream transformation. Research-grade material is adequate for exploratory peptide coupling, whereas high-purity grade is specified when residual imidazole-containing esters or over-acylated species cannot be purged by crystallization. Lot-to-lot variance in residual methanol and water has a greater effect on anhydrous coupling performance than the assay difference between these grades, so the certificate of analysis must be reviewed for the specific coupling solvent system.

    What Is Gained by Methyl Ester Dihydrochloride Formation Versus the Free Amino Acid?

    Free L-histidine is a zwitterionic amino acid with high aqueous solubility and poor solubility in non-protic organic media. The methyl ester removes the carboxylate anion and prevents carboxylate-driven aggregation in DMF, NMP, and dichloromethane after neutralization. In the dihydrochloride form, both the α-amino group and the imidazole ring are protonated, which suppresses premature N-acylation and stabilizes the otherwise low-melting free ester as a crystalline salt. Two equivalents of a tertiary amine are required for in situ liberation of the free base before coupling. The free base of H-His-OMe is generally a low-melting solid or viscous oil and is more prone to atmospheric carbon dioxide absorption; the dihydrochloride therefore offers a more reproducible salt form for automated and manual solution-phase synthesis. Compared with L-histidine monohydrochloride monohydrate, H-His-OMe·2HCl no longer carries the free carboxylate and does not form zwitterionic aggregates after neutralization in polar aprotic solvents. The differences are summarized in the following table.

    ParameterL-HistidineL-Histidine monohydrochloride monohydrateL-Histidine methyl ester dihydrochloride
    Molecular weight155.15209.63242.10
    C-terminal functionfree carboxylic acidfree carboxylic acidmethyl ester
    Salt stoichiometrynone1 HCl, 1 H₂O2 HCl
    Solubility profilewaterwaterwater, methanol; DMF after neutralization
    Typical synthetic rolezwitterionic amino acid building blockhydrochloride amino acid building blockC-terminal ester intermediate

    Release specifications for this non-pharmacopoeial derivative are vendor-defined rather than governed by a single USP or EP monograph. Identity is confirmed by ATR-FTIR and by chromatographic retention time relative to a qualified reference standard. The chloride content is a critical release parameter because incomplete salt formation alters the base stoichiometry required for downstream coupling. A chloride value below 28.5% or above 29.5% can indicate retained water, free base content, or excess hydrogen chloride and must be resolved before batch acceptance. Residual methanol and ethyl acetate are commonly reported under USP <467>; the ester is prepared from L-histidine in methanolic hydrogen chloride, and both solvents must be controlled to defined limits to avoid side reactions with acyl chlorides. When anhydrous coupling requires water content below 0.10%, vacuum drying at 40–50 °C for 4–6 h is typical. Published data for specific industrial-scale tray-drying endpoints is limited, so drying curves should be validated per batch.

    Release parameterTypical acceptance criterionAnalytical method
    Appearancewhite to off-white crystalline powdervisual
    Assay≥98.0% areaHPLC, USP <621>, C18, 210 nm
    Loss on drying≤0.50%USP <731>
    Chloride content28.5–29.5%titration, USP <541>
    Residual solventsconforms to Class 3 limitsUSP <467>, ICH Q3C
    Identityretention time and ATR-FTIR matchin-house reference standard

    Solubility-Driven Process Windows in Anhydrous Coupling Reactions

    In a typical solution-phase coupling, H-His-OMe·2HCl is suspended in anhydrous DMF or dichloromethane and treated with 2.0–2.2 equivalents of N,N-diisopropylethylamine or N-methylmorpholine. The base first neutralizes the hydrochloride salts; the liberated free ester then dissolves into the reaction medium. If fewer than two equivalents of base are used, residual protonation at the α-amino group slows acyl transfer and produces persistent insolubles. If more than 2.5 equivalents are used, the imidazole nitrogen can deprotonate sufficiently to compete as a nucleophile, yielding N-acylimidazole side products. For carbodiimide-mediated couplings with EDC/HOBt, the carboxyl component is pre-activated separately, and the histidine ester free base is added at 0–4 °C to limit racemization. Excess base relative to the carboxylic acid can also promote oxazolone formation in the activated acid and increase epimerization at the histidine Cα centre. The practical process window is therefore narrow: 2.0–2.2 equivalents of base, a solvent water content below 0.02%, and a holding temperature between 0 °C and 5 °C during the initial 30 min of coupling.

    On preparative scales above 100 mmol, the neutralization and coupling sequence is executed in glass-lined or 316L stainless steel reactors equipped with internal temperature probes and nitrogen blanketing. The initial suspension in DMF can become transiently thick as the free base dissolves after base addition; a controlled base addition rate of 0.5–1.0 equivalents per hour prevents localized pH excursions and reduces imidazole acylation. Agitation is maintained at 80–120 rpm for a 50 L reactor to keep the salt from settling before neutralization. Batch-to-batch variation in hydrochloride stoichiometry can occur when the product is exposed to humid air during charging; pre-dried solids and a nitrogen-purged charge chute are recommended. If a persistent haze remains after two equivalents of base, the batch may contain free L-histidine from partial hydrolysis, and the reactor contents should be checked by HPLC before addition of the activated carboxyl component.

    When Imidazole Protonation Influences Acylation Selectivity

    Selectivity between the α-amino group and the imidazole ring of H-His-OMe·2HCl is governed by protonation and solvent polarity. Under mildly acidic conditions, the imidazole remains predominantly protonated and is unreactive toward acyl chlorides, permitting α-amino acylation after partial neutralization. In fully neutralized or alkaline media, the imidazole pKa near 6.0 means that operation above pH 7.5 creates a significant concentration of free imidazole base, which can react with acyl chlorides, sulfonyl chlorides, or activated esters. For selective α-amino functionalization, the reaction is often buffered with a tertiary amine and kept below pH 7.0 in aqueous acetonitrile. When both nitrogens are to be acylated, excess acyl chloride under Schotten-Baumann conditions can be used, but methyl ester hydrolysis accelerates above pH 8.0. These side reactions are not observed to the same extent with Nα-Boc-N(π)-Trt-L-histidine methyl ester, which contains a protected α-amino group and a trityl-protected imidazole. The choice between unprotected H-His-OMe·2HCl and fully orthogonally protected histidine esters therefore depends on whether the imidazole will be used as a nucleophile or must remain inert.

    In solid-phase peptide synthesis, the methyl ester dihydrochloride is more commonly used as a solution-phase C-terminal fragment rather than as a resin-bound building block, because ester linkages are not retained on standard Wang or 2-chlorotrityl resins under repeated piperidine or trifluoroacetic acid treatment. When the product is coupled to a resin-bound amine, the neutralized free base is generated immediately before coupling, and the reaction is performed in DMF or NMP with HATU and 2.0–2.5 equivalents of collidine or DIPEA. The imidazole side chain remains unprotected in this strategy; resin cleavage conditions that generate the free peptide acid must be designed to avoid methyl ester hydrolysis at the histidine C-terminus if the ester is still present. The use of H-His-OMe·2HCl as a solution-phase fragment allows the final methyl ester to be saponified using lithium hydroxide in tetrahydrofuran/water at 0–5 °C, yielding the free acid without disturbing acid-sensitive side-chain protecting groups.

    Storage, Drying, and Incompatibility Limits

    The solid is hygroscopic and should be transferred under nitrogen where ambient relative humidity exceeds 60%. Agglomeration or caking indicates moisture uptake and requires vacuum drying before use in water-sensitive coupling. Aqueous solutions are not stable for long hold times: methyl ester hydrolysis to L-histidine and methanol occurs at measurable rates above pH 6.0 and above 25 °C. For pilot-scale synthesis, aqueous stock solutions are prepared immediately before use and held at 2–8 °C for no longer than 24 h unless stability data support longer windows. The dihydrochloride is incompatible with strong oxidizing agents. Wet chloride residues should be removed promptly from carbon steel surfaces to limit pitting corrosion; Halar-lined vacuum filters or 316L stainless steel equipment are preferred for isolation.

    Methyl ester hydrolysis is more rapid under alkaline conditions than under acid conditions. At pH 8.0 and 25 °C, hydrolysis to L-histidine can become significant within 24 h; at pH 4.0 the ester is substantially more stable, but the dihydrochloride is still best handled as a dry solid for water-sensitive applications. Methanol generated by hydrolysis can act as a nucleophile in subsequent coupling steps, leading to methyl ester transesterification side products. Residual methanol in the dried solid above 3000 ppm is therefore a concern for anhydrous acyl chloride processes; it should be reduced by vacuum drying or azeotropic treatment with toluene before use.

    Top